Unknown

Dataset Information

0

Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1?/VEGF secretion axis.


ABSTRACT: Anti-angiogenesis is currently considered as one of the major antitumor strategies for its protective effects against tumor emergency and later progression. The anti-diabetic drug metformin has been demonstrated to significantly inhibit tumor angiogenesis based on recent studies. However, the mechanism underlying this anti-angiogenic effect still remains an enigma. In this study, we investigated metformin-induced inhibitory effect on tumor angiogenesis in vitro and in vivo. Metformin pretreatment significantly suppressed tumor paracrine signaling-induced angiogenic promotion even in the presence of heregulin (HRG)-?1 (a co-activator of HER2) pretreatment of HER2+ tumor cells. Similar to that of AG825, a specific inhibitor of HER2 phosphorylation, metformin treatment decreased both total and phosphorylation (Tyr 1221/1222) levels of HER2 protein and significantly reduced microvessel density and the amount of Fitc-conjugated Dextran leaking outside the vessel. Furthermore, our results of VEGF-neutralizing and -rescuing tests showed that metformin markedly abrogated HER2 signaling-induced tumor angiogenesis by inhibiting VEGF secretion. Inhibition of HIF-1? signaling by using RNAi or YC-1, a specific inhibitor of HIF-1? synthesis, both completely diminished mRNA level of VEGF and greatly inhibited endothelial cell proliferation promoted by HER2+ tumor cell-conditioned medium in both the absence and presence of HRG-?1 pretreatment. Importantly, metformin treatment decreased the number of HIF-1? nucleus positive cells in 4T1 tumors, accompanied by decreased microvessel density. Our data thus provides novel insight into the mechanism underlying the metformin-induced inhibition of tumor angiogenesis and indicates possibilities of HIF-1?-VEGF signaling axis in mediating HER2-induced tumor angiogenesis.

SUBMITTER: Wang J 

PROVIDER: S-EPMC4792577 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.

Wang Jichang J   Li Guangyue G   Wang Yaochun Y   Tang Shouching S   Sun Xin X   Feng Xuefei X   Li Yan Y   Bao Gang G   Li Pingping P   Mao Xiaona X   Wang Maode M   Liu Peijun P  

Oncotarget 20151201 42


Anti-angiogenesis is currently considered as one of the major antitumor strategies for its protective effects against tumor emergency and later progression. The anti-diabetic drug metformin has been demonstrated to significantly inhibit tumor angiogenesis based on recent studies. However, the mechanism underlying this anti-angiogenic effect still remains an enigma. In this study, we investigated metformin-induced inhibitory effect on tumor angiogenesis in vitro and in vivo. Metformin pretreatmen  ...[more]

Similar Datasets

| S-EPMC8143977 | biostudies-literature
| S-EPMC7401288 | biostudies-literature
| S-EPMC10405507 | biostudies-literature
| S-EPMC5691891 | biostudies-literature
| S-EPMC5668468 | biostudies-literature
| S-EPMC8339006 | biostudies-literature
| S-EPMC8237315 | biostudies-literature
| S-EPMC8082391 | biostudies-literature
| S-EPMC5459903 | biostudies-literature
| S-EPMC4616885 | biostudies-other